Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-02

Clinical Trial Update: A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update of Xiang-Sha-Liu-Jun-Zi-Tang for irritable bowel syndrome (Phase 2/Phase 3). Status: UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xiang-Sha-Liu-Jun-Zi-Tang

Snippet

Sponsor: China Medical University Hospital | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: UNKNOWN